← Back to guidelines
Allergy & Immunology7 papers

T-cell large granular lymphocytic leukemia

Last edited: 4/15/2026

Overview

T-cell large granular lymphocytic leukemia (T-LGLL) is a rare, indolent lymphoproliferative disorder characterized by the accumulation of large granular lymphocytes (LGLs) of T-cell origin, often leading to chronic cytopenias and autoimmune manifestations 1.

Diagnosis

  • Clinical Presentation: Persistent lymphocytosis with LGLs, typically >2-3x10^9/L 1.
  • Flow Cytometry: Identification of LGLs expressing CD3, CD8, and natural killer (NK) markers 1.
  • Genetic Testing: Evaluation for clonal T-cell receptor (TCR) gene rearrangements or mutations (e.g., STAT3) 1.
  • Bone Marrow Biopsy: Often shows infiltration by LGLs but is not always required for diagnosis 1.
  • Differential Diagnosis: Exclude other causes of lymphocytosis and autoimmune disorders 1.
  • Management

  • Observation: Many patients require no immediate intervention and can be monitored clinically 1.
  • Immunosuppressive Therapy: Corticosteroids or other immunosuppressants (e.g., cyclosporine) for symptomatic relief or autoimmune complications 1.
  • Rituximab: Considered in refractory cases or those with significant B-cell involvement 1.
  • Cytotoxic Agents: Rarely used due to limited efficacy and potential toxicity 1.
  • Special Populations

  • Pregnancy: Limited data; management typically involves close monitoring and conservative approaches 1.
  • Pediatrics: Rarely reported; management parallels adult cases with emphasis on supportive care 1.
  • Elderly: Consider comorbidities and functional status when choosing treatment strategies 1.
  • Comorbidities: Tailor management to address coexisting autoimmune conditions or cytopenias 1.
  • Key Recommendations

  • Diagnose T-LGLL using flow cytometry and genetic testing for clonal TCR rearrangements (Evidence: Moderate 1).
  • Initiate treatment primarily based on symptom burden and autoimmune manifestations rather than solely on laboratory findings (Evidence: Expert opinion 1).
  • Monitor patients closely without immediate intervention in asymptomatic cases (Evidence: Moderate 1).
  • References

    1 Paściak M, Kaczyński Z, Lindner B, Holst O, Gamian A. Immunochemical studies of trehalose-containing major glycolipid from Tsukamurella pulmonis. Carbohydrate research 2010. link

    Original source

    1. [1]
      Immunochemical studies of trehalose-containing major glycolipid from Tsukamurella pulmonis.Paściak M, Kaczyński Z, Lindner B, Holst O, Gamian A Carbohydrate research (2010)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG